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A Case of Ramsay Hunt Syndrome with 
Atypical Presentation
Atipik Prezentasyonlu Bir Ramsay Hunt Sendromu Olgusu
ÖZET
Ramsay Hunt sendromu, varisella-zoster virüsün latent olarak kaldığı 
genikulat ganglionda aktifleşmesiyle oluşan herpes zosterin nadir bir 
komplikasyonudur. Ramsay Hunt sendromunda fasiyal sinir en sık et-
kilenen sinir olmasına rağmen diğer kraniyal sinirler ve servikal sinirler 
de tutulabilir. Bu yazıda, 42 yaşındaki erkek hastada servikal tutulumun 
da eşlik ettiği atipik bir Ramsay Hunt sedromu olgusu sunuldu. Ramsay 
Hunt sedromunda spontan iyileşme oranları düşük olduğundan bu has-
taların tanılarının erken dönemde konması ve tedavilerinin hemen baş-
lanması paralizinin tam olarak iyileşmesinde kilit role sahiptir.
Anahtar sözcükler: Fasiyal paralizi; Ramsay Hunt sendromu; varisella-zoster 
virüs.
SUMMARY
Ramsay Hunt syndrome is a rare complication of herpes zoster 
which results from the reactivation of the latent varicella-zoster vi-
rus in the geniculate ganglion. Although facial nerve is the most 
common affected nerve in Ramsay Hunt syndrome, other cranial 
and cervical nerves can also be affected. We present an atypical 
case of Ramsay Hunt syndrome in a 42-year-old male, with cervical 
nerve involvement. As spontaneous recovery rate in Ramsay Hunt 
syndrome is low, early diagnosis and treatment plays a key role in 
full recovery of paralysis.
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Introduction
Ramsay Hunt Syndrome (RHS), also known as Herpes Zos-
ter Oticus, was first defined by James Ramsay Hunt in 1907.
[1] The disease is a rare complication of the primary varicella 
zoster virus infection (VZV). Activated many years after inoc-
ulation, VZV is followed by a latency period in the geniculate 
ganglion and spreads along the sensory tract of the facial 
nerve. Ipsilateral facial paralysis, otalgia, and vesicular rash 
of the skin of external auditory canal compose the classical 
triad of the disease. In contrary to Bell’s palsy, the patients 
who are untreated or delayed in their treatment have poor 
prognosis and the full recovery rate is as low as 10-30% in 
these patients.[2,3] RHS is also known as cranial polyneuropa-
thy and besides facial nerve, cranial nerves 5, 8, 9, 10, 11, 12, 
and C2-C4 cervical nerves may also be affected. The eighth 
cranial nerve is the most common involved nerve together 
with facial nerve, while the others are rarely involved.[4] 
Here, we report a case of RHS, in which C2-C4 cervical nerves 
are affected together with the facial nerve.
Case Report
A 42-year-old man presented to our emergency department 
with the complaints of redness, numbness, and pain around 
left eye and face following an episode of otalgia, otorrhea, 
decreased hearing, and swelling of the left ear lasting three 
days. He did not have any chronic disease and medication 
history. His vital signs were as follows: blood pressure, 140/90 
mmHg; heart rate, 76 bpm; respiratory rate, 16/minute; and 
temperature, 36.7 ºC. Physical examination revealed edema 
of the external auditory canal and auricula of the left ear with 
a vesicular rash and serous discharge, periorbital and facial 
erythema and edema, stage 2 peripheric facial paralysis on 
the left side and vesicular rash of the left anterior cervical 
region (Figure 1a-c). Ophtalmic examination revealed no 
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pathological findings. Hematological or biochemical find-
ings were not substantial except a white blood cell count of 
14.6 K/mL. The patient was hospitalized with the diagnosis 
of RHS and acyclovir 10 mg/kg/day and prednisolone 1 mg/
kg/day were initiated. Following the regression of his clinical 
symptoms and physical findings, he was discharged at the 
third day of his admittance for ambulatory treatment and 
follow-up.
Discussion
In United States of America, it is estimated that one out of 
every three people are infected by VZV.[5] However, clini-
cal findings of herpes zoster do not develop in all infected 
subjects. The population based herpes zoster incidence was 
reported as 22.4 / 10,000 in a prospective study conducted 
by Paul and Thiel.[6] RHS develops in 0.2% of primary herpes 
zoster infections.[5] The incidence of the disease demon-
strated an increase after fifth decade and peaked at eighth 
decade, parallel to the decreasing cellular immunity with the 
aging process. It is 20% more common in females compared 
to males.[7]
The present case developed facial paralysis and vesicles 
around the left ear and neck following an episode of otal-
gia, otorrhea, decreased hearing, and swelling of the left ear, 
which lasted three days. Vesicular rash may manifest prior 
to or following facial paralysis or may not be observed at 
any time. When present, these vesicles may be observed at 
the external auditory canal, auricule, skin of the cheeks, the 
anterior two thirds of the tongue, hard palate, or cervical 
region.[4] Our patient had vesicles at the external auditory 
canal, auricule, and anterior cervical region with no presen-
tation in other regions. The key clinical finding is facial paral-
ysis and RHS, which covers 12% of cases with non-traumatic 
facial paralysis.[7] Otalgia is the second most common symp-
tom and 73% of the patients manifest otalgia as a complaint.
[2] Involvement of the vestibulocochlear nerve together with 
facial nerve is observed in 50% of the cases, causing hearing 
loss, vertigo, nausea, vomiting and nystagmus.[4] Dysphagia, 
disturbances of gaze and taste, double vision suggest in-
volvement of other cranial nerves. Furthermore, cardiac ar-
rhythmias may develop when vagal nerve is involved.[2,4] Our 
patient did not have any cranial nerve involvement other 
than facial nerve.
The cervical involvement observed in our case is not a typi-
cal finding in RHS.[5] Three different theories are proposed 
for this clinical situation. The first theory is spreading of VZV 
through cerebrospinal fluid (CSF) or by hematogenous way. 
In 38% of the cases with cutaneous herpes zoster, pleocyto-
sis is detected in CSF.[8] Another study reported presence of 
21% of the VZV in CSF of the patients manifesting cutane-
ous lesions.[9] The second proposed theory is the presence of 
anastomoses between cervical nerves and branches of the 
facial nerve as an anatomical variation, leading to the spread 
of inflammation to more than one dermatome along these 
anastomoses.[5,10] The last theory is the simultaneous activa-
tion of the virus in more than one ganglion, causing clinical 
symptoms.[5]
The case presented here was diagnosed clinically. There was 
no need for ancillary laboratory or imaging studies. RHS is 
a clinical diagnosis with the unilateral facial paresis, otalgia 
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Figure 1.  (a) Left facial palsy and periorbital edema. (b) Vesicular rash on the left face and periauricular region with serous 
auricular discharge. (c) Vesicular rash on the left anterior cervical region.
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and vesicular rash in ipsilateral ear, hard palate, and the an-
terior two third of the tongue being sufficient for diagnosis. 
It is hard to differentiate between RHS and Bell’s palsy when 
vesicles are not present in patients. Complement fixation 
tests and increased antibody levels may support the diagno-
sis. The detection of the virus by polymerase chain reaction 
in mononuclear cells of external auditory canal fluid, tear, 
CSF, and blood is accepted as the gold-standard in diagno-
sis of VZV.[11] Jonsson et al. evaluated the cases with facial 
paralysis and reported that there were no extra benefits of 
contrast enhanced magnetic resonance imaging for either 
diagnosis or prognosis of the patients.[12] 
There are not so many randomized, prospective controlled 
studies for RHS in the medical literature. The data is most-
ly based on the case reports and retrospective case series. 
The actual management is starting with a combination of 
an antiviral agent and steroids.[13] The most commonly used 
antiviral agent is acyclovir, however; a new generation anti-
viral drugs such as valacyclovir, famciclovir, penciclovir, and 
brivudine are being preferred due to increasing resistance.
[14] Prednisolone is suggested as the drug of choice for ste-
roid therapy. In a retrospective study, Murakami et al. com-
pared the effectiveness of the combination therapy of acy-
clovir and prednisolone with prednisolone therapy alone. 
They concluded that the full neurological recovery rate of 
the combination therapy group was significantly higher 
than the group treated merely with prednisolone. More-
over, when patients were grouped according to the time of 
initiation of drug therapy, the group in which therapy was 
initiated in the first three days showed a full neurological re-
covery rate of 75%. The rate decreased to 48% in the second 
group in which therapy was initiated in 4 to 7 days similar 
to the decrease of 30% in the third group in which therapy 
was initiated in later than 7 days. There was no clinically sig-
nificant difference between therapeutic effects of parenteral 
and oral administration of acyclovir.[3] Kinishi et al. compared 
the groups of patients who started acyclovir alone and pred-
nisolene alone therapy in the first seven days. They reported 
significantly better nerve stimulation test results in the acy-
clovir alone group.[15]
Since patients suffer from severe pain, pain management 
must also be taken into consideration in addition to the 
treatments mentioned above. Cellulitis may develop follow-
ing infection of the vesicles, necessitating antibiotic therapy. 
Following discharge from the hospital, most of the patients 
need rehabilitation and long term follow-up.[5] Our patient 
was administered a combination therapy of acyclovir and 
prednisolone after the clinical diagnosis was made. He was 
discharged at the third day for ambulatory treatment and 
follow-up.
The most important aspect of RHS when compared to Bell’s 
palsy is the significantly worse prognosis when left untreat-
ed. In non-treated patients or patients in whom treatment 
was started later than seven days, the full neurological re-
covery rate is significantly as low as 10 to 30%. Advanced 
age, involvement of more than one cranial nerve, and a 
higher stage of facial paralysis during first admittance are 
well-defined prognostic indicators of RHS.[2,3] The absence of 
the prognostic factors as well as the early initiation of ther-
apy yielded full neurological recovery in the present case, 
consistent with the literature. The most common complica-
tion of RHS is postherpetic neuralgia that increases with age. 
Meningoencephalitis, myelitis, cerebrovascular problems 
associated with vasculitis, ventriculitis, and cerebral venous 
thrombosis may also develop.[4] Examination of our patient 
during follow-up visits indicated  no development of any of 
these listed complications.
Conclusion
RHS is a medical emergent condition necessitating early 
diagnosis and treatment in order to have a good progno-
sis. In patients with facial paralysis but no external vesicular 
findings, otoscopic and audiometric examinations must be 
performed. The combination therapy with antivirals and ste-
roids must be initiated as soon as possible in order to mini-
mize the risk of permanent neuronal damage.
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